journal article·2026-04Open access

Inflammation-targeted single-atom nanozymes drive microglial depolarization and inhibit ferroptosis via Sirt-6-xCT-GPX4 axis to attenuate early brain injury following subarachnoid hemorrhage

Boliang Liu, Chao Xiang, Xiaodan Zhang, Wei Guo, Haitao Wu, Fandi Hou, Yueyang Ba, Xiulei Zhang, Zhongcan Chen, Guang Feng, Yuan Dang, Yang Zhu, Jianjun Gu

Abstract

Early brain injury (EBI) has been identified as a key factor leading to the poor prognosis of patients with subarachnoid hemorrhage (SAH). At present, apart from surgical treatment, there is a lack of effective neuroprotective drugs. In this study, a biomimetic nanozyme V-MDL-800 was constructed by coordinating Vanadium Single-atom enzymes (V/SAE) and the allosteric activator MDL-800 of Sirt6, and encapsulated into NM@V-MDL-800 with neutropenia cell membrane (NM). By clearing ROS, the xCT/GPX4 pathway was activated, blocking the pathophysiological process of EBI after SAH can improve prognosis. NM@V-MDL-800 recruits through the blood-brain barrier (BBB) at the site of hemorrhagic injury by relying on the chemotactic property of neutrophils. Among them, the catalase-like, superoxide dismutase-like, and hydroxyl radical scavenging effects of V/SAE can eliminate excessive reactive oxygen species (ROS) within cells and inhibit oxidative stress; at the same time, as an allosteric activator of Sirt6, it activates the downstream xCT/GPX4 pathway, improving lipid metabolism abnormalities. Regulating the key core pathway of lipid peroxidation on ferroptosis promotes the polarization of microglia from the pro-inflammatory M1 form to the anti-inflammatory M2 morphology to inhibit the pathophysiological process of neuroinflammation in EBI. In addition, in vivo imaging of mice confirmed the targeted effect of NM@V-MDL-800 through the blood-brain barrier and recruited at the site of bleeding injury. The therapeutic effect of NM@V-MDL-800 on the SAH model has also been confirmed in vivo and in vitro experiments. This provides new ideas for SAH drug therapy regimens of SAH targeting microglial ferroptosis.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Intracranial Aneurysms: Treatment and Complications · Advanced Nanomaterials in Catalysis · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (53)

Show source-provided references
1. Spontaneous subarachnoid haemorrhage10.1016/S0140-6736(16)30668-7 ↗
2. Aneurysmal subarachnoid hemorrhage: the last decade10.1007/s12975-020-00867-0 ↗
3. Worldwide incidence of aneurysmal subarachnoid hemorrhage according to Region, time period, blood pressure, and smoking prevalence in the population: a systematic review and meta-analysis10.1001/jamaneurol.2019.0006 ↗
4. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review10.1016/S1474-4422(09)70025-0 ↗
5. Inflammation in the brain after experimental subarachnoid hemorrhage
6. Ferroptosis: an iron-dependent form of nonapoptotic cell death10.1016/j.cell.2012.03.042 ↗
7. Blocking hepatoma-derived growth factor attenuates vasospasm and Neuron cell apoptosis in rats subjected to Subarachnoid hemorrhage10.1007/s12975-021-00928-y ↗
8. Regulation of ferroptotic cancer cell death by GPX410.1016/j.cell.2013.12.010 ↗
9. Molecular basis for redox control by the human cystine/glutamate antiporter system xc(11)10.1038/s41467-021-27414-1 ↗
10. Oroxin A alleviates early brain injury after subarachnoid hemorrhage by regulating ferroptosis and neuroinflammation10.1186/s12974-024-03099-3 ↗
11. Microglia accumulation and activation after subarachnoid hemorrhage10.4103/1673-5374.303028 ↗
12. Excessive phospholipid peroxidation distinguishes ferroptosis from other cell death modes including pyroptosis10.1038/s41419-020-03118-0 ↗
13. Redox lipid reprogramming commands susceptibility of macrophages and microglia to ferroptotic death10.1038/s41589-019-0462-8 ↗
14. Ferroptosis and necroinflammation, a yet poorly explored link10.1038/s41418-018-0173-9 ↗
15. MDM2-GPX4-ferroptosis regulatory axis exerts neurotoxic effects in intracerebral hemorrhage
16. Deacetylase SIRT2 inhibition promotes microglial M2 polarization through Axl/PI3K/AKT to alleviate White matter injury after subarachnoid Hemorrhage10.1007/s12975-024-01282-5 ↗
17. LRP1 activation attenuates white matter injury by modulating microglial polarization through Shc1/PI3K/Akt pathway after subarachnoid hemorrhage in rats10.1016/j.redox.2019.101121 ↗
18. A CoQ10 analog ameliorates cognitive impairment and early brain injury after subarachnoid hemorrhage by regulating ferroptosis and neuroinflammation10.1016/j.redox.2025.103684 ↗
19. The blood-brain barrier in health and disease: important unanswered questions10.1084/jem.20190062 ↗
20. Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging10.1016/j.nano.2011.05.016 ↗
21. Injectable, long-acting PLGA formulations: analyzing PLGA and understanding microparticle formation10.1016/j.jconrel.2019.05.003 ↗
22. Nanoparticles improved resveratrol brain delivery and its therapeutic efficacy against intracerebral hemorrhage10.1039/D0NR06249A ↗
23. Vanadium in biological action: Chemical, pharmacological aspects, and metabolic implications in diabetes mellitus10.1007/s12011-018-1540-6 ↗
24. The age of vanadium-based nanozymes: synthesis, catalytic mechanisms, regulation and biomedical applications10.1016/j.cclet.2023.108793 ↗
25. Natural polyphenol-vanadium oxide nanozymes for synergistic Chemodynamic/Photothermal therapy10.1002/chem.202002335 ↗
26. Vanadium oxide nanozymes with multiple enzyme-mimic activities for tumor catalytic therapy
27. 2D vanadium carbide MXenzyme to alleviate ROS-mediated inflammatory and neurodegenerative diseases10.1038/s41467-021-22278-x ↗
28. Emerging therapeutic potential of SIRT6 modulators10.1021/acs.jmedchem.1c00601 ↗
29. SIRT6 prevent chronic cerebral hypoperfusion induced cognitive impairment by remodeling mitochondrial dynamics in a STAT5-PGAM5-Drp1 dependent manner10.1186/s12967-024-05566-0 ↗
30. Neuroprotective functions for the histone deacetylase SIRT610.1016/j.celrep.2017.03.008 ↗
31. The immunology of acute stroke10.1038/nrneurol.2012.98 ↗
32. Thrombosis, neuroinflammation, and poststroke infection: the multifaceted role of neutrophils in stroke10.1155/2017/5140679 ↗
33. Cell membrane coating nanotechnology10.1002/adma.201706759 ↗
34. Neutrophil-like cell-membrane-coated nanozyme therapy for ischemic brain damage and long-term neurological functional recovery10.1021/acsnano.0c07973 ↗
35. An antioxidant nanozyme that uncovers the cytoprotective potential of vanadia nanowires10.1038/ncomms6301 ↗
36. Self-assembly of multi-nanozymes to mimic an intracellular antioxidant defense system10.1002/anie.201600868 ↗
37. Biomimetic nanoparticles enhance recovery of movement disorders in Parkinson's disease by improving microglial mitochondrial homeostasis and suppressing neuroinflammation10.1021/acsami.4c22181 ↗
38. Platelet membrane-coated Curcumin-PLGA nanoparticles promote Astrocyte-Neuron transdifferentiation for intracerebral hemorrhage treatment10.1002/smll.202311128 ↗
39. Catalytic oxidations by vanadium complexes10.1016/S0010-8545(02)00308-9 ↗
40. Influence of VO2 nanoparticle morphology on the colorimetric assay of H2O2 and glucose10.3390/nano7110347 ↗
41. Sirt6 overexpression relieves ferroptosis and delays the progression of diabetic nephropathy via Nrf2/GPX4 pathway10.1080/0886022X.2024.2377785 ↗
42. The SIRT6/BAP1/xCT signaling axis mediates ferroptosis in cisplatin-induced AKI10.1016/j.cellsig.2024.111479 ↗
43. Baicalin induces ferroptosis in osteosarcomas through a novel Nrf2/xCT/GPX4 regulatory axis10.1016/j.phymed.2023.154881 ↗
44. Optimization and evaluation of an experimental subarachnoid hemorrhage model in mice
45. A new grading system evaluating bleeding scale in filament perforation subarachnoid hemorrhage rat model10.1016/j.jneumeth.2007.08.004 ↗
46. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation10.1161/01.STR.26.4.627 ↗
47. Melatonin alleviates early brain injury by inhibiting the NRF2-mediated ferroptosis pathway after subarachnoid hemorrhage10.1016/j.freeradbiomed.2023.09.012 ↗
48. Evaluation of learning and memory mechanisms employing elevated plus-maze in rats and mice10.1016/0278-5846(92)90014-6 ↗
49. Noninvasive brain stimulation protects cognitive impairment in i.c.v. STZ-Injected rats: role of adult neurogenesis10.1111/ejn.70277 ↗
50. Ruthenium single-atom nanozyme driven sonosensitizer with oxygen vacancies enhances electron–hole separation efficacy and remodels tumor microenvironment for sonodynamic-amplified ferroptosis
51. Engineering local coordination environment of manganese single-atom enzyme for amplified infected wound therapy10.1016/j.cej.2025.163247 ↗
52. Neutrophil membrane-based biomimetic metal-polyphenol self-assembled nanozyme for the targeting treatment of early brain injury following subarachnoid hemorrhage10.1016/j.cej.2024.155643 ↗
53. Metal-polyphenol self-assembled nanodots for NIR-II fluorescence imaging-guided chemodynamic/photodynamic therapy-amplified ferroptosis10.1016/j.actbio.2024.07.017 ↗